Page last updated: 2024-10-31

mitoxantrone and Bradyarrhythmia

mitoxantrone has been researched along with Bradyarrhythmia in 4 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Umemoto, M1
Kawasaki, H1
Azuma, E1
Komada, Y1
Ito, M1
Sakurai, M1
Benekli, M1
Kars, A1
Güler, N1
Chan-Tack, K2

Other Studies

4 other studies available for mitoxantrone and Bradyarrhythmia

ArticleYear
Bradycardia due to mitoxantrone exacerbated by previous anthracycline therapy.
    American journal of hematology, 1996, Volume: 52, Issue:4

    Topics: Anthracyclines; Antineoplastic Agents; Bradycardia; Child; Child, Preschool; Drug Interactions; Huma

1996
Mitoxantrone-induced bradycardia.
    Annals of internal medicine, 1997, Mar-01, Volume: 126, Issue:5

    Topics: Adult; Antineoplastic Agents; Bradycardia; Female; Humans; Male; Middle Aged; Mitoxantrone; Precurso

1997
Sinus bradycardia due to mitoxantrone.
    Southern medical journal, 2000, Volume: 93, Issue:4

    Topics: Aged; Antineoplastic Agents; Bradycardia; Female; Humans; Leukemia, Myeloid, Acute; Mitoxantrone

2000
Sinus bradycardia secondary to mitoxantrone.
    Missouri medicine, 2000, Volume: 97, Issue:6

    Topics: Aged; Antineoplastic Agents; Bradycardia; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acut

2000